Application

15999458 · Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

Filed 2018-08-17 · Granted · Patent 10807974 (2020-10-20) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Kristin Ann Vajda Easy · CPC C07D 333/34 · THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL · Morgan, Lewis & Bockius LLP (SF)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

10.7 mo

to disposition 26.1 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.